David Ting is listed as a director on 8 SEC Form D filings by 1 issuer between Jun 2015 and Dec 2022: PanTher Therapeutics, Inc. (Austin, TX — biotechnology — 2015–2022; $7.33M reported sold to 59 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Laura Indolfi (8 shared filings), Elazer Edelman (5 shared filings), Darshana Zaveri (3 shared filings), Manish Bhandari (3 shared filings) and Maria Palasis (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for David Ting and found 9 differences, 2 worth asking the sponsor about: Form D filed 343 days after the first sale; Form D filed 646 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.